A More Appropriate Cardiac Troponin T Level That Can Predict Outcomes in End-Stage Renal Disease Patients with Acute Coronary Syndrome
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Cardiac troponin T (cTnT), a useful marker for diagnosing acute myocardial infarction (AMI) in the general population, is significantly higher than the usual cut-off value in many end-stage renal disease (ESRD) patients without clinically apparent evidence of AMI. The aim of this study was to evaluate the clinical usefulness of cTnT in ESRD patients with acute coronary syndrome (ACS). Materials and Methods: Two hundred eighty-four ESRD patients with ACS were enrolled between March 2002 and February 2008. These patients were followed until death or June 2009. Medical records were reviewed retrospectively. The cut-off value of cTnT for AMI was evaluated using a receiver operating characteristic (ROC) curve. We calculated Kaplan-Meier survival curves, and potential outcome predictors were determined by Cox proportional hazard analysis. Results: AMIs were diagnosed in 40 patients (14.1%). The area under the curve was 0.98 in the ROC curve (p<0.001; 95% CI, 0.95-1.00). The summation of sensitivity and specificity was highest at the initial cTnT value of 0.35 ng/mL (sensitivity, 0.95; specificity,0.97). Survival analysis showed a statistically significant difference in all-cause and cardiovascular mortalities for the group with an initial cTnT ≥0.35 ng/mL compared to the other groups. Initial serum cTnT concentration was an independent predictor for mortality. Conclusion: Because ESRD patients with an initial cTnT concentration ≥0.35 ng/mL have a poor prognosis, it is suggested that urgent diagnosis and treatment be indicated in dialysis patients with ACS when the initial cTnT levels are ≥0.35 ng/mL.
Abstract
Purpose: Cardiac troponin T (cTnT), a useful marker for diagnosing acute myocardial infarction (AMI) in the general population, is significantly higher than the usual cut-off value in many end-stage renal disease (ESRD) patients without clinically apparent evidence of AMI. The aim of this study was to evaluate the clinical usefulness of cTnT in ESRD patients with acute coronary syndrome (ACS). Materials and Methods: Two hundred eighty-four ESRD patients with ACS were enrolled between March 2002 and February 2008. These patients were followed until death or June 2009. Medical records were reviewed retrospectively. The cut-off value of cTnT for AMI was evaluated using a receiver operating characteristic (ROC) curve. We calculated Kaplan-Meier survival curves, and potential outcome predictors were determined by Cox proportional hazard analysis. Results: AMIs were diagnosed in 40 patients (14.1%). The area under the curve was 0.98 in the ROC curve (p<0.001; 95% CI, 0.95-1.00). The summation of sensitivity and specificity was highest at the initial cTnT value of 0.35 ng/mL (sensitivity, 0.95; specificity,0.97). Survival analysis showed a statistically significant difference in all-cause and cardiovascular mortalities for the group with an initial cTnT ≥0.35 ng/mL compared to the other groups. Initial serum cTnT concentration was an independent predictor for mortality. Conclusion: Because ESRD patients with an initial cTnT concentration ≥0.35 ng/mL have a poor prognosis, it is suggested that urgent diagnosis and treatment be indicated in dialysis patients with ACS when the initial cTnT levels are ≥0.35 ng/mL.
참고문헌 (30)
- Farias MA, "A prospective comparison of methods for determining if cardiovascular disease is a predictor of mortality in dialysis patients", Am J Kidney Dis, 23, pp.382~388 (1994)
- Parfrey PS, "The clinical epidemiology of cardiac disease in chronic renal failure", J Am Soc Nephrol, 10, pp.1606~1615 (1999)
- Sarnak MJ, "Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention", Circulation, 108, pp.2154~2169 (2003)
- Cheung AK, "Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study", Kidney Int, 65, pp.2380~2389 (2004)
- Foley RN, "Clinical epidemiology of cardiovascular disease in chronic renal disease", Am J Kidney Dis, 32, pp.S112~S119 (1998)
- Joki N, "Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease", Nephrol Dial Transplant, 12, pp.718~723 (1997)
- Collins AJ, "Cardiovascular disease in end-stage renal disease patients", Am J Kidney Dis, 38, pp.S26~S29 (2001)
- Sosnov J, "Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective", Am J Kidney Dis, 47, pp.378~384 (2006)
- Willging S, "Specificity of cardiac troponins I and T in renal disease", Clin Chem Lab Med, 36, pp.87~92 (1998)
- McLaurin MD, "Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle", Clin Chem, 43, pp.976~982 (1997)
- Khan NA, "Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis", Circulation, 112, pp.3088~3096 (2005)
- Aviles RJ, "Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction", N Engl J Med, 346, pp.2247~2052 (2002)
- Alpert JS, "Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology", American College of Cardiology Committee for the redefinition of myocardial infarction, 2000, pp.36, 959~969
- Wu AH, "Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction", Clin Chem, 40, pp.900~907 (1994)
- Apple FS, "European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials", Am Heart J, 144, pp.981~986 (2002)
- Apple FS, "Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease", Circulation, 106, pp.2941~2945 (2002)
- Freda BJ, "Cardiac troponins in renal insufficiency: review and clinical implications", J Am Coll Cardiol, 40, pp.2065~2071 (2002)
- Hamm CW, "Cardiac troponin elevations in patients without acute coronary syndrome", Circulation, 106, pp.2871~2872 (2002)
- Diris JH, "Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients", Circulation, 109, pp.23~25 (2004)
- Soffer O, "Creatine phosphokinase in long-term dialysis patients", Arch Intern Med, 141, pp.181~188 (1981)
- McLaurin MD, "Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle", Clin Chem, 43, pp.976~982 (1997)
- Apple FS, "Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis", Am J Kidney Dis, 29, pp.399~403 (1997)
- Kleiman NS, "Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes", J Am Coll Cardiol, 40, pp.1044~1050 (2002)
- Newby LK, "Christenson RH, Pollack CV Jr, et al. Frequency and clinical implications of discor dant creatine kinase-MB and troponin measurements in acute coronary syndromes", J Am Coll Cardiol, 47, pp.312~318 (2006)
- Dierkes J, "Cardiac troponin T predicts mortality in patients with end-stage renal disease", Circulation, 102, pp.1964~1969 (2000)
- Deegan PB, "Prognostic value of troponin T in hemodialysis patients is independent of comorbidity", Kidney Int, 60, pp.2399~2405 (2001)
- deFilippi C, "Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis", JAMA, 290, pp.353~359 (2003)
- Havekes B, "NECOSAD Study Group. Serum troponin T concentration as a predictor of mortality in hemodialysis and peritoneal dialysis patients", Am J Kidney Dis, 47, pp.823~829 (2006)
- Jung HH, "Elevated concentrations of cardiac troponins are associated with severe coronary artery calcification in asymptomatic haemodialysis patients", Nephrol Dial Transplant, 19, pp.3117~3123 (2004)
- Kontos MC, "Outcomes in patients admitted for chest pain with renal failure and troponin I elevations", Am Heart J, 150, pp.674~680 (2005)